The reactivity of human serum albumin toward trans-4-hydroxy-2-nonenal

Journal of Mass Spectrometry

Volumn 47, Issue 4, 2012, Pages 411-424

  Liu, Qingyuan ^a   Simpson, David C ^a   Gronert, Scott ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Hydroxynonenal; ITRAQ; Mass spectrometry; Oxidative stress; Protein carbonyl

Indexed keywords

MASS SPECTROMETRY; OXIDATIVE STRESS; PROTEINS; REACTION RATES;

HIGH MASS ACCURACIES; HUMAN SERUM ALBUMINS; HYDROXYNONENAL; ITRAQ; PHYSIOLOGICAL CONDITION; PROTEIN CARBONYLS; REACTION CONDITIONS; SECONDARY REACTIONS;

AMINO ACIDS;

4 HYDROXYNONENAL; CYSTINE; HISTIDINE; HUMAN SERUM ALBUMIN; LYSINE; PHOSPHATE BUFFERED SALINE;

AMINO ACID SEQUENCE; ARTICLE; KINETICS; MICHAEL ADDITION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 84861567190     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.2037     Document Type: Article

References (60)

1. B. S. Berlett, E. R. Stadtman. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272, 20313.
2. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, A. Milzani. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52, 601.
3. I. Dalle-Donne, A. Scaloni, D. Giustarini, E. Cavarra, G. Tell, G. Lungarella, R. Colombo, R. Rossi, A. Milzani. Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics. Mass Spectrom. Rev. 2005, 24, 55.
4. T. Finkel, N. J. Holbrook. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408, 239.
5. A. Nyska, R. Kohen. Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 2002, 30, 620.
6. E. R. Stadtman. Protein oxidation and aging. Science 1992, 257, 1220.
7. H. Mirzaei, F. Regnier. Affinity chromatographic selection of carbonylated proteins followed by identification of oxidation sites using tandem mass spectrometry. Anal. Chem. 2005, 77, 2386.
8. R. L. Levine. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radical Biol. Med. 2002, 32, 790.
9. I. Dalle-Donne, D. Giustarini, R. Colombo, R. Rossi, A. Milzani. Protein carbonylation in human diseases. Trends Mol. Med. 2003, 9, 169.
10. I. Dalle-Donne, G. Aldini, M. Carini, R. Colombo, R. Rossi, A. Milzani. Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 2006, 10, 389.
11. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, R. Colombo. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329, 23.
12. H. Mirzaei, F. Regnier. Identification and quantification of protein carbonylation using light and heavy isotope labeled Girard's P reagent. J. Chromatogr. A 2006, 1134, 122.
13. D. L. Meany, H. W. Xie, L. V. Thompson, E. A. Arriaga, T. J. Griffin. Identification of carbonylated proteins from enriched rat skeletal muscle mitochondria using affinity chromatography-stable isotope labeling and tandem mass spectrometry. Proteomics 2007, 7, 1150.
14. T. Nystrom. Role of oxidative carbonylation in protein quality control and senescence. EMBO J. 2005, 24, 1311.
15. P. J. O'Brien, A. G. Siraki, N. Shangari. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 2005, 35, 609.
16. N. A. Porter. Chemistry of lipid-peroxidation. Methods Enzymol. 1984, 105, 273.
17. H. Esterbauer, R. J. Schaur, H. Zollner. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 1991, 11, 81.
18. D. R. Petersen, J. A. Doorn. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radical Biol. Med. 2004, 37, 937.
19. K. Uchida. 4-hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog. Lipid Res. 2003, 42, 318.
20. G. Poli, R. J. Schaur, W. G. Siems, G. Leonarduzzi. 4-hydroxynonenal: A membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 2008, 28, 569.
21. L. Gil, W. Siems, B. Mazurek, J. Gross, P. Schroeder, P. Voss, T. Grune. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radical Res. 2006, 40, 495.
22. H. J. Forman, J. M. Fukuto, T. Miller, H. Q. Zhang, A. Rinna, S. Levy. The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch. Biochem. Biophys. 2008, 477, 183.
23. I. Kruman, A. J. BruceKeller, D. Bredesen, G. Waeg, M. P. Mattson. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 1997, 17, 5089.
24. A. Yoritaka, N. Hattori, K. Uchida, M. Tanaka, E. R. Stadtman, Y. Mizuno. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 2696.
25. L. M. Sayre, D. A. Zelasko, P. L. R. Harris, G. Perry, R. G. Salomon, M. A. Smith. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 1997, 68, 2092.
26. X. X. Tang, L. M. Sayre, G. P. Tochtrop. A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c. J. Mass Spectrom. 2011, 46, 290.
27. N. Rauniyar, L. Prokai. Detection and identification of 4-hydroxy-2-nonenal Schiff-base adducts along with products of Michael addition using data-dependent neutral loss-driven MS3 acquisition: Method evaluation through an in vitro study on cytochrome c oxidase modifications. Proteomics 2009, 9, 5188.
28. N. Rauniyar, S. M. Stevens, K. Prokai-Tatrai, L. Prokai. Characterization of 4-hydroxy-2-nonenal-modified peptides by liquid chromatography-tandem mass spectrometry using data-dependent acquisition: Neutral loss-driven MS(3) versus neutral loss-driven electron capture dissociation. Anal. Chem. 2009, 81, 782.
29. S. M. Stevens, N. Rauniyar, L. Prokai. Rapid characterization of covalent modifications to rat brain mitochondrial proteins after ex vivo exposure to 4-hydroxy-2-nonenal by liquid chromatographytandem mass spectrometry using data-dependent and neutral lossdriven MS3 acquisition. J. Mass Spectrom. 2007, 42, 1599.
30. M. Carini, G. Aldini, R. M. Facino. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrom. Rev. 2004, 23, 281.
31. M. S. Bolgar, S. J. Gaskell. Determination of the sites of 4-hydroxy-2-nonenal adduction to protein by electrospray tandem mass spectrometry. Anal. Chem. 1996, 68, 2325.
32. B. A. Bruenner, A. D. Jones, J. B. German. Direct characterization of protein adducts of the lipid-peroxidation product 4-hydroxy-2-nonenal using electrospray mass-spectrometry. Chem. Res. Toxicol. 1995, 8, 552.
33. N. Rauniyar, K. Prokai-Tatrai, L. Prokai. Identification of carbonylation sites in apomyoglobin after exposure to 4-hydroxy-2-nonenal by solid-phase enrichment and liquid chromatography-electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 2010, 45, 398.
34. G. Aldini, L. Gamberoni, M. Orioli, G. Beretta, L. Regazzoni, R.M. Facino, M. Carini. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. J. Mass Spectrom. 2006, 41, 1149.
35. M. E. Szapacs, J. N. Riggins, L. J. Zimmerman, D. C. Liebler. Covalent adduction of human serum albumin by 4-hydroxy-2-nonenal: Kinetic analysis of competing alkylation reactions. Biochemistry 2006, 45, 10521.
36. G. Aldini, G. Vistoli, L. Regazzoni, L. Gamberoni, R. M. Facino, S. Yamaguchi, K. Uchida, M. Carini. Albumin is the main nucleophilic target of human plasma: A protective role against pro-atherogenic electrophilic reactive carbonyl species. Chem. Res. Toxicol. 2008, 21, 824.
37. G. Colombo, G. Aldini, M. Orioli, D. Giustarini, R. Gornati, R. Rossi, R. Colombo, M. Carini, A. Milzani, I. Dalle-Donne. Water-soluble alpha,beta-unsaturated aldehydes of cigarette smoke induce carbonylation of human serum albumin. Antioxid. Redox Signal. 2010, 12, 349.
38. D. Giustarini, A. Milzani, R. Colombo, I. Dalle-Donne, R. Rossi. Nitric oxide and S-nitrosothiols in human blood. Clin. Chim. Acta 2003, 330, 85.
39. X. M. He, D. C. Carter. Atomic-structure and chemistry of human serum-albumin. Nature 1992, 358, 209.
40. P. L. Ross, Y. L. N. Huang, J. N.Marchese, B.Williamson, K. Parker, S. Hattan, N. Khainovski, S. Pillai, S. Dey, S. Daniels, S. Purkayastha, P. Juhasz, S. Martin, M. Bartlet-Jones, F. He, A. Jacobson, D. J. Pappin. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154.
41. S. Wiese, K. A. Reidegeld, H. E. Meyer, B. Warscheid. Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research. Proteomics 2007, 7, 340.
42. T. J. Griffin, H. W. Xie, S. Bandhakavi, J. Popko, A. Mohan, J. V. Carlis, L. Higgins. iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer. J. Proteome Res. 2007, 6, 4200.
43. Y. Riahi, G. Cohen, O. Shamni, S. Sasson. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E879.
44. J. Oneil, G. Hoppe, L. M. Sayre, H. F. Hoff. Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme. Free Radical Biol. Med. 1997, 23, 215.
45. L. I. Szweda, K. Uchida, L. Tsai, E. R. Stadtman. Inactivation of glucose-6-phosphate-dehydeogenase by 4-hydroxy-2-nonenal: Selective modification of an active-site lysine. J. Biol. Chem. 1993, 268, 3342.
46. M. Umrethia, V. L. Kett, G. P. Andrews, R. K. Malcolm, A. D. Woolfson. Selection of an analytical method for evaluating bovine serum albumin concentrations in pharmaceutical polymeric formulations. J. Pharm. Biomed. Anal. 2010, 51, 1175.
47. J. V. Olsen, B. Macek, O. Lange, A. Makarov, S. Horning, M. Mann. Higher-energy C-trap dissociation for peptide modification analysis. Nat. Methods 2007, 4, 709.
48. A. Keller, A. I. Nesvizhskii, E. Kolker, R. Aebersold. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383.
49. H. Choi, A. I. Nesvizhskii. Semisupervised model-based validation of peptide identifications in mass spectrometry-based proteomics. J. Proteome Res. 2008, 7, 254.
50. J. W. Crabb, J. O'Neil, M. Miyagi, K. West, H. F. Hoff. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Sci. 2002, 11, 831.
51. G. Aldini, L. Regazzoni, M. Orioli, I. Rimoldi, R. M. Facino, M. Carini. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: A new tool for studying vascular carbonylation. J. Mass Spectrom. 2008, 43, 1470.
52. M. Kleinova, O. Belgacem, K. Pock, A. Rizzi, A. Buchacher, G. Allmaier. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19, 2965.
53. J. C. Schwartz, J. E. P. Syka, S. T. Quarmby. Improving the Fundamentals of MSn on 2D Linear Ion Traps: New Ion Activation and Isolation Techniques. Proceedings of the 53rd ASMS Conference on Mass Spectrometry and Allied Topics, San Antonio, TX, June 5-9, 2005.
54. D. L. Tabb, D. B. Friedman, A. J. L. Ham. Verification of automated peptide identifications from proteomic tandem mass spectra. Nat. Protoc. 2006, 1, 2213.
55. A. A. Bhattacharya, S. Curry, N. P. Franks. Binding of the general anesthetics propofol and halothane to human serum albumin: High resolution crystal structures. J. Biol. Chem. 2000, 275, 38731.
56. T. J. Richmond. Solvent accessible surface-area and excluded volume in proteins: Analytical equations for overlapping spheres and implications for the hydrophobic effect. J. Mol. Biol. 1984, 178, 63.
57. R. Fraczkiewicz, W. Braun. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J. Comput. Chem. 1998, 19, 319.
58. R. Fraczkiewicz, W. Braun. University of Texas Medical Branch, Galveston, Texas, 2008. http://curie.utmb.edu/getarea.html
59. S. Curry, H. Mandelkow, P. Brick, N. Franks. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 1998, 5, 827.
60. I. Petitpas, T. Grune, A. A. Bhattacharya, S. Curry. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 2001, 314, 955.